AC Immune SA (ACIU)
2.42
+0.02
(+0.83%)
USD |
NASDAQ |
Oct 15, 10:53
AC Immune Total Long Term Debt (Quarterly) : 5.085M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.085M |
| March 31, 2026 | 5.356M |
| December 31, 2025 | 5.732M |
| September 30, 2025 | 5.858M |
| June 30, 2025 | 6.180M |
| March 31, 2025 | 5.849M |
| December 31, 2024 | 5.988M |
| September 30, 2024 | 3.655M |
| June 30, 2024 | 3.593M |
| March 31, 2024 | 3.696M |
| December 31, 2023 | 4.155M |
| September 30, 2023 | 2.616M |
| June 30, 2023 | 2.827M |
| March 31, 2023 | 2.918M |
| December 31, 2022 | 3.027M |
| September 30, 2022 | 2.524M |
| June 30, 2022 | 2.744M |
| March 31, 2022 | 3.009M |
| December 31, 2021 | 3.194M |
| September 30, 2021 | 2.754M |
| June 30, 2021 | 2.918M |
| March 31, 2021 | 2.281M |
| Date | Value |
|---|---|
| December 31, 2020 | 2.515M |
| September 30, 2020 | 2.103M |
| June 30, 2020 | 2.153M |
| March 31, 2020 | 2.220M |
| December 31, 2019 | 2.329M |
| September 30, 2019 | 2.196M |
| June 30, 2019 | 2.292M |
| March 31, 2019 | 2.316M |
| December 31, 2018 | 0.1887M |
| September 30, 2018 | 0.6061M |
| June 30, 2018 | 0.5579M |
| March 31, 2018 | 0.4543M |
| December 31, 2017 | 0.4053M |
| September 30, 2017 | 0.4051M |
| June 30, 2017 | 0.4031M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Precigen, Inc. | 97.29M |
| Basilea Pharmaceutica AG | 0.00 |
| Santhera Pharmaceuticals Holding AG | 0.00 |
| Aldeyra Therapeutics, Inc. | 0.00 |
| BeOne Medicines Ltd. | 1.808B |